124 related articles for article (PubMed ID: 37517600)
21. Definition of gross tumor volume in lung cancer: inter-observer variability.
Van de Steene J; Linthout N; de Mey J; Vinh-Hung V; Claassens C; Noppen M; Bel A; Storme G
Radiother Oncol; 2002 Jan; 62(1):37-49. PubMed ID: 11830311
[TBL] [Abstract][Full Text] [Related]
22. 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer.
Wang H; Vees H; Miralbell R; Wissmeyer M; Steiner C; Ratib O; Senthamizhchelvan S; Zaidi H
Radiother Oncol; 2009 Nov; 93(2):220-5. PubMed ID: 19767115
[TBL] [Abstract][Full Text] [Related]
23. Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.
Bird D; Scarsbrook AF; Sykes J; Ramasamy S; Subesinghe M; Carey B; Wilson DJ; Roberts N; McDermott G; Karakaya E; Bayman E; Sen M; Speight R; Prestwich RJ
BMC Cancer; 2015 Nov; 15():844. PubMed ID: 26530182
[TBL] [Abstract][Full Text] [Related]
24. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.
Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S
Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour.
Gaudreault M; Chang D; Hardcastle N; Jackson P; Kron T; Hofman MS; Siva S
Clin Transl Radiat Oncol; 2022 Jul; 35():84-89. PubMed ID: 35662883
[TBL] [Abstract][Full Text] [Related]
26. A multimodality segmentation framework for automatic target delineation in head and neck radiotherapy.
Yang J; Beadle BM; Garden AS; Schwartz DL; Aristophanous M
Med Phys; 2015 Sep; 42(9):5310-20. PubMed ID: 26328980
[TBL] [Abstract][Full Text] [Related]
27. Deep-Learning-Based Artificial Intelligence for PI-RADS Classification to Assist Multiparametric Prostate MRI Interpretation: A Development Study.
Sanford T; Harmon SA; Turkbey EB; Kesani D; Tuncer S; Madariaga M; Yang C; Sackett J; Mehralivand S; Yan P; Xu S; Wood BJ; Merino MJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2020 Nov; 52(5):1499-1507. PubMed ID: 32478955
[TBL] [Abstract][Full Text] [Related]
28. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
29. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy.
De Meerleer G; Villeirs G; Bral S; Paelinck L; De Gersem W; Dekuyper P; De Neve W
Radiother Oncol; 2005 Jun; 75(3):325-33. PubMed ID: 15967524
[TBL] [Abstract][Full Text] [Related]
30. Targeting prostate lesions on multiparametric MRI with HDR brachytherapy: Optimal planning margins determined using whole-mount digital histology.
Smith CW; Marcus T; Hoover D; Surry K; D'Souza D; Cool D; Kassam Z; Bastian-Jordan M; Gómez JA; Moussa M; Chin JL; Pautler S; Bauman GS; Ward AD
Brachytherapy; 2022; 21(4):435-441. PubMed ID: 35337747
[TBL] [Abstract][Full Text] [Related]
31. Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy.
Pollack A; Chinea FM; Bossart E; Kwon D; Abramowitz MC; Lynne C; Jorda M; Marples B; Patel VN; Wu X; Reis I; Studenski MT; Casillas J; Stoyanova R
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):305-315. PubMed ID: 32084522
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy Boost for the Dominant Intraprostatic Cancer Lesion-A Systematic Review and Meta-Analysis.
von Eyben FE; Kiljunen T; Kangasmaki A; Kairemo K; von Eyben R; Joensuu T
Clin Genitourin Cancer; 2016 Jun; 14(3):189-97. PubMed ID: 26768965
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies.
Terezakis SA; Schöder H; Kowalski A; McCann P; Lim R; Turlakov A; Gonen M; Barker C; Goenka A; Lovie S; Yahalom J
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):376-83. PubMed ID: 24726287
[TBL] [Abstract][Full Text] [Related]
34. Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy.
Deurloo KE; Steenbakkers RJ; Zijp LJ; de Bois JA; Nowak PJ; Rasch CR; van Herk M
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):228-38. PubMed ID: 15629616
[TBL] [Abstract][Full Text] [Related]
35. Focal boost to residual gross tumor volume in brachytherapy for cervical cancer-A feasibility study.
Thiruthaneeswaran N; Groom N; Lowe G; Bryant L; Hoskin PJ
Brachytherapy; 2018; 17(1):181-186. PubMed ID: 29153466
[TBL] [Abstract][Full Text] [Related]
36. MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial.
Zapatero A; Roch M; Castro Tejero P; Büchser D; Martin de Vidales C; González S; Rodríguez P; San Jose LA; Celada G; Murillo MT
Br J Radiol; 2022 Mar; 95(1131):20210683. PubMed ID: 34538073
[TBL] [Abstract][Full Text] [Related]
37. Intraindividual Comparison Between [
Marinescu IM; Spohn SKB; Kiefer S; Bronsert P; Ceci L; Holzschuh J; Sigle A; Jilg CA; Rühle A; Sprave T; Nicolay NH; Winzer R; Rehm J; Kotzerke J; Hölscher T; Grosu AL; Ruf J; Benndorf M; Zamboglou C
Front Oncol; 2022; 12():880042. PubMed ID: 35912219
[TBL] [Abstract][Full Text] [Related]
38. Automatic intraprostatic lesion segmentation in multiparametric magnetic resonance images with proposed multiple branch UNet.
Chen Y; Xing L; Yu L; Bagshaw HP; Buyyounouski MK; Han B
Med Phys; 2020 Dec; 47(12):6421-6429. PubMed ID: 33012016
[TBL] [Abstract][Full Text] [Related]
39. Clinical Evaluation of Deep Learning for Tumor Delineation on
Kovacs DG; Ladefoged CN; Andersen KF; Brittain JM; Christensen CB; Dejanovic D; Hansen NL; Loft A; Petersen JH; Reichkendler M; Andersen FL; Fischer BM
J Nucl Med; 2024 Feb; 65(4):623-9. PubMed ID: 38388516
[TBL] [Abstract][Full Text] [Related]
40. Gross tumor volume delineation in primary prostate cancer on
Zhang YN; Lu ZG; Wang SD; Lu X; Zhu LL; Yang X; Fu LP; Zhao J; Wang HF; Xiang ZL
Cancer Imaging; 2022 Jul; 22(1):36. PubMed ID: 35869521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
